Related Experiment Videos
Enantiomers in arthritic disorders
1Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Darlinghurst, NSW, Australia.
Pharmacology & Therapeutics
|January 1, 1990
Summary
Many drugs exist as enantiomers, with one form potentially causing side effects while the other provides therapeutic benefits. Understanding these asymmetric drugs is crucial for drug development and understanding inflammation.
Area of Science:
- Pharmacology
- Medicinal Chemistry
- Drug Discovery
Background:
- Chiral drugs are often prescribed as racemic mixtures (equal parts enantiomers).
- Significant differences in how the body processes (pharmacokinetics) and responds to (pharmacodynamics) enantiomers are common.
- This can lead to one enantiomer being therapeutic while the other causes adverse effects.
Purpose of the Study:
- To review the significance of enantiomers in drug action.
- To highlight the role of asymmetric drugs as pharmacological tools.
- To discuss their impact on anti-inflammatory and antirheumatic therapies.
Main Methods:
- Literature review of studies on chiral drugs.
- Analysis of pharmacodynamic and pharmacokinetic data for enantiomers.
- Exploration of the use of asymmetric drugs in research.
Main Results:
- Enantiomers of a drug can have vastly different effects.
- One enantiomer may be responsible for therapeutic action, while the other contributes to toxicity.
- Asymmetric drugs offer insights into drug mechanisms and inflammation.
Conclusions:
- Developing single-enantiomer drugs can improve efficacy and reduce side effects.
- Asymmetric drugs are valuable for elucidating drug mechanisms and inflammatory pathways.
- Further research into enantiomer-specific effects is warranted for optimized therapeutics.